The average retail price of Ozempic is roughly $1,475 per month without insurance. The manufacturer’s list price is lower, at $1,027.51 per pen, but what you actually pay at the pharmacy counter depends heavily on your insurance, your dose, and whether you qualify for any savings programs.
List Price vs. What You Pay at the Pharmacy
Novo Nordisk sets the wholesale acquisition cost (the price before any discounts or rebates) at $1,027.51 per pen, regardless of whether it’s the 0.5 mg, 1 mg, or 2 mg dose. That number is the same across all three strengths. But the wholesale price isn’t what shows up on your pharmacy receipt. After markups and distribution costs, the average retail price that uninsured customers face at pharmacies like CVS, Walgreens, and Walmart lands around $1,475 per carton.
Novo Nordisk raised the list price by 3% at the start of 2025, continuing a pattern of annual increases that has pushed the cost steadily higher over the past several years.
Cost With Commercial Insurance
If you have private insurance through an employer or marketplace plan, your out-of-pocket cost varies widely. Some plans cover Ozempic with a specialty-tier copay of $50 to $150 per month, while others require coinsurance that can leave you paying several hundred dollars. Plans that don’t include Ozempic on their formulary may not cover it at all, leaving you responsible for the full retail price.
Novo Nordisk offers a savings card for people with commercial insurance that can reduce your copay. This card is not available to anyone on Medicare or Medicaid. Your doctor’s office or pharmacy can check whether you qualify and apply it at the point of sale.
Medicare Part D Coverage
Medicare beneficiaries who qualify for the Medicare GLP-1 Bridge program pay a flat $50 copay per fill. That copay stays the same no matter which phase of the Part D benefit you’re in, and it applies even to beneficiaries who would otherwise receive low-income cost-sharing subsidies. One important detail: the $50 copay does not count toward your annual out-of-pocket maximum under Part D.
Options Without Insurance
If you’re uninsured, Novo Nordisk now offers a direct pricing program for people with type 2 diabetes. Existing patients can get the 0.25 mg, 0.5 mg, or 1 mg pens for $349 per month, or the 2 mg pen for $499 per month. These prices represent a significant discount from the $1,475 retail average, though they still add up to $4,188 to $5,988 per year.
Discount platforms like GoodRx advertise coupons that can bring the price down to around $199 for certain versions, an 86% discount off the average retail price. Availability and pricing through these coupons can change depending on your pharmacy and location.
Novo Nordisk also runs a patient assistance program that provides the medication at no cost to eligible patients. To qualify, your total household income needs to be at or below 400% of the federal poverty level, and you cannot have private prescription coverage. Medicare patients who meet the other requirements may still qualify, but the program generally excludes those eligible for Medicaid.
Compounded Semaglutide: A Cheaper Alternative
Compounded versions of semaglutide, made by specialty pharmacies rather than Novo Nordisk, typically cost between $129 and $497 per month. These versions are not FDA-approved and are mixed to order based on a prescription. The quality, concentration, and reliability can vary significantly between providers. Compounded semaglutide occupies a legally gray area that has been the subject of ongoing regulatory scrutiny, so availability may shift over time.
How U.S. Prices Compare Internationally
The price gap between the United States and other countries is substantial. Canadians pay between $300 and $500 per month for GLP-1 medications including Ozempic, roughly a third to a quarter of what uninsured Americans pay at retail. This disparity is consistent with broader patterns in drug pricing, where the U.S. market bears significantly higher costs than countries with government-negotiated pricing.
Why Dose Doesn’t Change the Price
One detail that surprises many patients: whether your doctor prescribes 0.5 mg, 1 mg, or 2 mg, the list price per pen is identical at $1,027.51. Retail prices follow the same pattern, hovering within a few cents of $1,475 regardless of dose strength. Each pen contains a different concentration but the same 3 mL volume, and Novo Nordisk prices them uniformly. This means that if your dose increases over time (as it typically does during the first few months of treatment), your monthly cost stays flat.